Kipnis; Jonathan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kipnis; Jonathan.The latest application filed is for "use of integrin inhibitors for treatment or prevention of a neurological immunity disorder and/or nervous system injury".

Company Profile

4.8.17

Kipnis; Jonathan - Charlottesville VA
KIPNIS; Jonathan - Modiin IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treatment of social dysfunction neurological disorders and seizures Grant 11,389,509 - Filiano , et al. July 19, 2	2022-07-19
Methods for treatment or prevention of a neurological immunity disorder Grant 11,312,775 - Kipnis , et al. April 26, 2	2022-04-26
Use Of Integrin Inhibitors For Treatment Or Prevention Of A Neurological Immunity Disorder And/or Nervous System Injury App 20220119532 - Kipnis; Jonathan ; et al.	2022-04-21
Compositions And Methods Of Diagnosis And Treatment For Neurological Diseases App 20210311076 - Kipnis; Jonathan ; et al.	2021-10-07
Compositions and Methods of Enhancing the Homing and/or Engraftment of Hematopoietic Cells in the Central Nervous System App 20200316039 - Filiano; Anthony ; et al.	2020-10-08
Methods For Treatment Or Prevention Of A Neurological Immunity Disorder App 20200172624 - Kipnis; Jonathan ; et al.	2020-06-04
Methods And Compostions For Modulating Lymphatic Vessels In The Central Nervous System App 20190269758 - Kipnis; Jonathan ; et al.	2019-09-05
Method And Vaccine Comprising Copolymer 1 For Treatment Of Psychiatric Disorders App 20180207249 - EISENBACH-SCHWARTZ; Michal ; et al.	2018-07-26
Vaccine and method for treatment of neurodegenerative diseases Grant 9,517,256 - Eisenbach-Schwartz , et al. December 13, 2	2016-12-13
Method And Vaccine Comprising Copolymer 1 For Treatment Of Psychiatric Disorders App 20160213762 - EISENBACH-SCHWARTZ; Michal ; et al.	2016-07-28
Vaccine and method for treatment of neurodegenerative diseases Grant 8,828,404 - Eisenbach-Schwartz , et al. September 9, 2	2014-09-09
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20140134196 - EISENBACH-SCHWARTZ; Michal ; et al.	2014-05-15
Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 App 20120135016 - Eisenbach-Schwartz; Michal ; et al.	2012-05-31
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20110206706 - Eisenbach-Schwartz; Michal ; et al.	2011-08-25
Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders App 20110117115 - Eisenbach-Schwartz; Michal ; et al.	2011-05-19
Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells App 20100168085 - Eisenbach-Schwartz; Michal ; et al.	2010-07-01
Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 App 20090191173 - Eisenbach-Schwartz; Michal ; et al.	2009-07-30
Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy Grant 7,407,936 - Eisenbach-Schwartz , et al. August 5, 2	2008-08-05
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20080085269 - Eisenbach-Schwartz; Michal ; et al.	2008-04-10
Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides Grant 7,351,686 - Eisenbach-Schwartz , et al. April 1, 2	2008-04-01
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy App 20050159336 - Eisenbach-Schwartz, Michal ; et al.	2005-07-21
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy Grant 6,844,314 - Eisenbach-Schwartz , et al. January 18, 2	2005-01-18
The use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy App 20030004099 - Eisenbach-schwartz, Michael ; et al.	2003-01-02
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy App 20020037848 - Eisenbach-Schwartz, Michal ; et al.	2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.